kabutan

Japan Animal Referral Medical, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 20%, Raises Record High Profit Forecast

Thu Nov 13, 2025 3:30 pm JST Earnings

6039 Japan Animal Referral Medical Center Co.,Ltd. 【J-GAAP】

Earnings Report

Japan Animal Referral Medical Center Co.,Ltd. <6039> [TSE Growth] announced its financial results after the market closed on November 13th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2026 (April to September) expanded 0.58 billion yen, an increase 67.8% compared to the same period last year.

In addition, the full-year forecast for consolidated ordinary profit has been revised upward 20.2%, from the previous forecast of 0.85 billion yen to 1.03 billion yen (compared to 0.72 billion yen in the previous period), increasing the growth rate from 19.0% to 43.1%, further surpassing the previous forecast of record-high profits for two consecutive terms.

Based on the first-half performance announced by the company and the full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to grow 19.5% from the same period last year, reaching 0.44 billion yen.

In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit increased 64.7% from the same period last year, reaching 0.33 billion yen. The operating profit margin jumped from 15.2% in the same period last year to 21.3%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2023 1,982 159 152 97 35.6 31.1 Nov 9, 2023 J-GAAP
Apr - Sep, 2024 2,569 350 351 242 93.5 48.8 Nov 7, 2024 J-GAAP
Apr - Sep, 2025 3,033 591 589 413 159.9 57.2 Nov 13, 2025 J-GAAP
YoY +18.1% +68.9% +67.8% +70.7% +70.9%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 Guidance ー ー ー ー － 0 May 15, 2025 J-GAAP
Apr - Sep, 2025 Results 3,033 591 589 413 159.9 0 Nov 13, 2025 J-GAAP
Revision Rate － － － － －

Guidance Update

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Prev 5,960 857 857 610 236.0 40 Aug 14, 2025 J-GAAP
Mar, 2026 New 6,100 1,040 1,030 730 282.4 40 Nov 13, 2025 J-GAAP
Revision Rate +2.3% +21.4% +20.2% +19.7% +19.7%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 2,708 370 369 278 107.5 37 May 15, 2025 J-GAAP
Oct - Mar, 2025 Guidance 3,067 449 441 317 122.6 40 Nov 13, 2025 J-GAAP
YoY +13.3% +21.4% +19.5% +14.0% +14.1%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 4,270 496 489 337 123.0 20 May 9, 2024 J-GAAP
Mar, 2025 5,277 720 720 520 201.1 37 May 15, 2025 J-GAAP
Mar, 2026 Guidance 6,100 1,040 1,030 730 282.4 40 Nov 13, 2025 J-GAAP
YoY +15.6% +44.4% +43.1% +40.4% +40.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2024 1,319 201 201 139 53.7 15.2 Nov 7, 2024 J-GAAP
Oct - Dec, 2024 1,373 240 239 167 64.5 17.5 Feb 14, 2025 J-GAAP
Jan - Mar, 2025 1,335 130 130 111 42.9 9.7 May 15, 2025 J-GAAP
Apr - Jun, 2025 1,473 258 258 180 69.8 17.5 Aug 14, 2025 J-GAAP
Jul - Sep, 2025 1,560 333 331 233 90.2 21.3 Nov 13, 2025 J-GAAP
YoY +18.3% +65.7% +64.7% +67.6% +67.9%

Related Articles